{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:44:57Z","timestamp":1794663897044,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.009","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T12:26:20Z","timestamp":1607171180000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Individual preferences for COVID-19 vaccination in China"],"prefix":"10.1016","volume":"39","author":[{"given":"Anli","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1551-4787","authenticated-orcid":false,"given":"Elizabeth","family":"Maitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.12.009_b0005","unstructured":"WHO. Coronavirus disease (COVID-19) pandemic-27 July 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 [accessed July 27, 2020]."},{"key":"10.1016\/j.vaccine.2020.12.009_b0010","unstructured":"WHO. DRAFT landscape of COVID-19 candidate vaccines\u201330 April 2020. https:\/\/www.who.int\/whodocuments-detail\/draft-landscape-of-COVID-19-candidate-vaccines [accessed May 5, 2020]."},{"issue":"34","key":"10.1016\/j.vaccine.2020.12.009_b0015","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1016\/j.vaccine.2020.06.068","article-title":"Contingent assessment of the COVID-19 vaccine","volume":"38","author":"Garc\u00eda","year":"2020","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2020.12.009_b0020","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1080\/10410236.2020.1838096","article-title":"Considering Emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence","volume":"35","author":"Chou","year":"2020","journal-title":"Health Commun"},{"key":"10.1016\/j.vaccine.2020.12.009_b0025","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Li-Hua Hou, et al., Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Feng-Cai","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2020.12.009_b0030","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1080\/21645515.2020.1790279","article-title":"The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay","volume":"16","author":"Wong","year":"2020","journal-title":"Hum Vacc Immunotherapeut"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.009_b0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/vaccines8030527","article-title":"Behavioral differences in the preference for hepatitis B virus vaccination: A discrete choice experiment","volume":"8","author":"Guo","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2020.12.009_b0040","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.vaccine.2014.07.002","article-title":"Parents' preferences for seasonal influenza vaccine for their children in Japan","volume":"32","author":"Shono","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.009_b0045","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.vaccine.2017.04.006","article-title":"The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment","volume":"35","author":"Guo","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.009_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.socscimed.2018.04.038","article-title":"Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives","volume":"207","author":"Verelst","year":"2018","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2020.12.009_b0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jval.2017.10.012","article-title":"Mothers' preferences and willingness to pay for human papillomavirus vaccination for their daughters: A discrete choice experiment in Hong Kong","volume":"21","author":"Wong","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2020.12.009_b0060","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s11538-015-0111-7","article-title":"Individual vaccination as Nash equilibrium in a SIR model with application to the 2009\u20132010 influenza A (H1N1) epidemic in France","volume":"77","author":"Laguzet","year":"2015","journal-title":"B Math Biol"},{"key":"10.1016\/j.vaccine.2020.12.009_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0272989X11427762","article-title":"Vaccinating to help ourselves and others","volume":"32","author":"Vietri","year":"2012","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.vaccine.2020.12.009_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(19)32686-8","article-title":"Lower trust in national government links to no history of vaccination","volume":"395","author":"Miyachi","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.12.009_b0090","first-page":"1","article-title":"In the wake of scandals: how media use and social trust influence risk perception and vaccination intention among Chinese parents","volume":"7716","author":"Liu","year":"2020","journal-title":"Health Commun"},{"key":"10.1016\/j.vaccine.2020.12.009_b0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40271-017-0244-x","article-title":"Individual preferences for child and adolescent vaccine attributes: a systematic review of the stated preference literature","volume":"10","author":"Christine","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.vaccine.2020.12.009_b0100","unstructured":"CDD Centers for disease control vaccine effectiveness \u2013 How well does the flu vaccine work? https:\/\/www.cdc.gov\/flu\/about\/qa\/vaccineeffect.htm, 2017. [accessed May 14, 2017]."},{"key":"10.1016\/j.vaccine.2020.12.009_b0105","doi-asserted-by":"crossref","first-page":"e5079","DOI":"10.1371\/journal.pone.0005079","article-title":"Estimation of influenza vaccine effectiveness from routine surveillance data","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.12.009_b0110","unstructured":"Yu HJ. The vaccination protection rate of HIN1 vaccine exceeds 85%. Persistence is still under observation. https:\/\/www.ixueshu.com\/document\/756eb25879eaa0d6318947a18e7f9386.html [accessed Nov 05, 2009] [in Chinese]."},{"key":"10.1016\/j.vaccine.2020.12.009_b0115","unstructured":"Deng HH, More than 150 cases of HINI vaccination have been reported abnormal reaction in more than 300,000 people nationwide. http:\/\/cn.chinagate.cn\/infocus\/2009-10\/10\/content_18678045.htm [accessed Oct 10, 2009] [in Chinese]."},{"key":"10.1016\/j.vaccine.2020.12.009_b0120","series-title":"Getting started with conjoint analysis: strategies for product design and pricing research","author":"Orme","year":"2010"},{"key":"10.1016\/j.vaccine.2020.12.009_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample size requirements for discrete-choice experiments in healthcare: a practical guide","volume":"8","author":"De Bekker-Grob","year":"2015","journal-title":"Patient"},{"key":"10.1016\/j.vaccine.2020.12.009_b0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jocm.2016.09.005","article-title":"Dummy coding vs effects coding for categorical variables: clarifications and extensions","volume":"21","author":"Daly","year":"2016","journal-title":"J Choice Model"},{"key":"10.1016\/j.vaccine.2020.12.009_b0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: A report of the ISPOR conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2020.12.009_b0140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhealeco.2007.11.006","article-title":"Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment","volume":"27","author":"Hole","year":"2008","journal-title":"J Health Econ"},{"key":"10.1016\/j.vaccine.2020.12.009_b0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jval.2011.05.003","article-title":"Patient preference for latent tuberculosis infection preventive treatment: A discrete choice experiment","volume":"14","author":"Guo","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2020.12.009_b0150","doi-asserted-by":"crossref","first-page":"e54149","DOI":"10.1371\/journal.pone.0054149","article-title":"The effect of perceived risks on the demand for vaccination: results from a discrete choice experiment","volume":"8","author":"Sadique","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:19Z","timestamp":1759402399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315760"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual preferences for COVID-19 vaccination in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}